Estimated number of deaths directly averted in people 60 years and older as a result of COVID-19 vaccination in the WHO European Region, December 2020 to November 2021
Jazyk angličtina Země Švédsko Médium print
Typ dokumentu časopisecké články
Grantová podpora
001
World Health Organization - International
PubMed
34823641
PubMed Central
PMC8619871
DOI
10.2807/1560-7917.es.2021.26.47.2101021
Knihovny.cz E-zdroje
- Klíčová slova
- COVID-19, deaths averted, expected mortality, older age groups, vaccination coverage, vaccination programs,
- MeSH
- COVID-19 * MeSH
- lidé MeSH
- SARS-CoV-2 MeSH
- Světová zdravotnická organizace MeSH
- vakcinace MeSH
- vakcíny proti COVID-19 * MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- vakcíny proti COVID-19 * MeSH
Since December 2019, over 1.5 million SARS-CoV-2-related fatalities have been recorded in the World Health Organization European Region - 90.2% in people ≥ 60 years. We calculated lives saved in this age group by COVID-19 vaccination in 33 countries from December 2020 to November 2021, using weekly reported deaths and vaccination coverage. We estimated that vaccination averted 469,186 deaths (51% of 911,302 expected deaths; sensitivity range: 129,851-733,744; 23-62%). Impact by country ranged 6-93%, largest when implementation was early.
Centre for Disease Prevention and Control of Latvia Riga Latvia
European Centre for Disease Prevention and Control Stockholm Sweden
French Public Health Agency Paris France
Health Directorate Luxembourg Luxembourg
Institute of Health Carlos 3 Madrid Spain
Instituto Superiore di Sanità Rome Italy
Israel Ministry of Health Jerusalem Israel
Ministry of Public Health Malta
National Institute of Public Health National Research Institute Warsaw Poland
National Institute of Public Health Prague Czechia
National Public Health Organization Athens Greece
Norwegian Institute of Public Health Olso Norway
Public Health Center of the MOH of Ukraine Kyiv Ukraine
Public Health Scotland Glasgow United Kingdom
UK Health Security Agency London United Kingdom
World Health Organization Regional Office for Europe Copenhagen Denmark
Zobrazit více v PubMed
World Health Organization Regional Office for Europe (WHO/Europe). Coronavirus disease (COVID-19) pandemic. Copenhagen: WHO/Europe. [Accessed: 20 Jul 2021]. Available from: https://www.euro.who.int/en/health-topics/health-emergencies/coronavirus-covid-19/novel-coronavirus-2019-ncov#
World Health Organization (WHO). Weekly epidemiological update on COVID-19 - 16 November 2021. Edition 66. Geneva: WHO; 2021. Available from: https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---16-november-2021
Galvani A, Moghadas S, Schneider E. Deaths and hospitalizations averted by rapid U.S. vaccination rollout. New York: Commonwealth Fund; 2021. Available from: https://www.commonwealthfund.org/publications/issue-briefs/2021/jul/deaths-and-hospitalizations-averted-rapid-us-vaccination-rolloutb
Public Health England (PHE). Impact of COVID-19 vaccines on mortality in England. December 2020 to March 2021. London: PHE; 2021.Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/977249/PHE_COVID-19_vaccine_impact_on_mortality_March.pdf
United Nations Department of Economic and Social Affairs Population Division. World population prospects 2019. New York: United Nations. [Accessed: 10 Mar 2021]. Available from: https://population.un.org/wpp/Download/Standard/Population
Eurostat. Demo_pjan. Luxembourg: Eurostat; 2020. [Accessed: 22 Feb 2021]. Available from: https://ec.europa.eu/eurostat/estat-navtree-portlet-prod/BulkDownloadListing?dir=data&sort=1&sort=2&start=d
Israeli Central Bureau of Statistics (CBS). Statistical Abstract of Israel 2021 - No.72. Jerusalem: CBS; 2021. [Accessed: 11 Oct 2021]. Hebrew. Available from: https://www.cbs.gov.il/he/publications/Pages/2021/%D7%A9%D7%A0%D7%AA%D7%95%D7%9F-%D7%A1%D7%98%D7%98%D7%99%D7%A1%D7%98%D7%99-%D7%9C%D7%99%D7%A9%D7%A8%D7%90%D7%9C-2021-%D7%9E%D7%A1%D7%A4%D7%A8-72.aspx
R Core Team. R: a language and environment for statistical computing. Vienna: R Foundation of Statistical Computing; 2016. Available from: https://www.R-project.org
Machado A, Mazagatos C, Dijkstra F, Kislaya I, Gherasim A, McDonald SA, et al. Impact of influenza vaccination programmes among the elderly population on primary care, Portugal, Spain and the Netherlands: 2015/16 to 2017/18 influenza seasons. Euro Surveill. 2019;24(45):1900268. 10.2807/1560-7917.ES.2019.24.45.1900268 PubMed DOI PMC
World Health Organization (WHO). COVID-Deaths-Averted-analysis. GitHub Repository. GitHub. [Accessed: 14 Sep 2021]. Available from: https://github.com/whocov/COVID-Deaths-Averted-analysis
Goldberg Y, Mandel M, Woodbridge Y, Fluss R, Novikov I, Yaari R, et al. Protection of previous SARS-CoV-2 infection is similar to that of BNT162b2 vaccine protection: A three-month nationwide experience from Israel. MedRxiv. 2021.04.20.21255670. Preprint. 10.1101/2021.04.20.21255670 PubMed DOI PMC
Andrews N, Tessier E, Stowe J, Gower C, Kirsebom F, Simmons R, et al. Vaccine effectiveness and duration of protection of Comirnaty, Vaxzevria and Spikevax against mild and severe COVID-19 in the UK. MedRxiv. 2021.09.15.21263583. Preprint. https://doi.org/10.1101/2021.09.15.21263583 DOI
Ranzani OT, Hitchings MDT, Dorion M, D’Agostini TL, de Paula RC, de Paula OFP, et al. Effectiveness of the CoronaVac vaccine in older adults during a gamma variant associated epidemic of covid-19 in Brazil: test negative case-control study. BMJ. 2021;374:n2015. 10.1136/bmj.n2015 PubMed DOI PMC
Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383(27):2603-15. 10.1056/NEJMoa2034577 PubMed DOI PMC
Hauser A, Counotte MJ, Margossian CC, Konstantinoudis G, Low N, Althaus CL, et al. Estimation of SARS-CoV-2 mortality during the early stages of an epidemic: A modeling study in Hubei, China, and six regions in Europe. PLoS Med. 2020;17(7):e1003189. 10.1371/journal.pmed.1003189 PubMed DOI PMC
García-García D, Vigo MI, Fonfría ES, Herrador Z, Navarro M, Bordehore C. Retrospective methodology to estimate daily infections from deaths (REMEDID) in COVID-19: the Spain case study. Sci Rep. 2021;11(1):11274. 10.1038/s41598-021-90051-7 PubMed DOI PMC
Bartsch SM, Wedlock PT, O’Shea KJ, Cox SN, Strych U, Nuzzo JB, et al. Lives and costs saved by expanding and expediting coronavirus disease 2019 vaccination. J Infect Dis. 2021;224(6):938-48. 10.1093/infdis/jiab233 PubMed DOI PMC
Victora PC, Castro PMC, Gurzenda S, Medeiros AC, França GVA, Barros PAJD. Estimating the early impact of vaccination against COVID-19 on deaths among elderly people in Brazil: Analyses of routinely-collected data on vaccine coverage and mortality. EClinicalMedicine. 2021;38:101036. 10.1016/j.eclinm.2021.101036 PubMed DOI PMC
Goldstein JR, Cassidy T, Wachter KW. Vaccinating the oldest against COVID-19 saves both the most lives and most years of life. Proc Natl Acad Sci USA. 2021;118(11):e2026322118. 10.1073/pnas.2026322118 PubMed DOI PMC